Email Updates

You are here

10 SEPTEMBER 2021 VOLUME 23 ISSUE 36

Media Coverage

  • The news on Aug. 31 was devastating: After a decade of research and development, Johnson & Johnson announced that its experimental HIV vaccine showed no clear ability to prevent infection. Such was the unhappy end of the so-called Imbokodo study—the word means a “grinding rock” in Zulu and is attached to a famous saying about the strength of women. ... The results showed 63 new HIV infections among the women who got the placebo and 51 among women who got the vaccine—hardly a big enough difference to suggest that the vaccine was a grand slam.

    September 9, 2021
    The Body
  • The war on drugs may profess to be waged against narcotics, but it overwhelmingly targets people—a view increasingly shared by experts on drug use. Nora Volkow, director of the National Institute on Drug Abuse, touched on this recently when she wrote about addiction stigma in STAT, noting that “societal norms surrounding drug use and addiction continue to be informed by myths and misconceptions.”

    September 9, 2021
    General
    Mother Jones
  • Rwanda is piloting the possibilities of making HIV-prevention pills—which are currently only accessible to key populations in the country—available to all.

    September 9, 2021
    The New Times
  • Kisumu County has recorded a higher number of discordant couples over the past five years due to increased access to Pre-Exposure Prophylaxis (PrEP), a new report shows. According to the report released on Wednesday by Jhpiego, an international health organisation under the Jilinde project, the county now has 1,930 discordant couples, up from 18 in 2017.

    September 9, 2021
    All Africa
  • Kenya has missed an important target to circumcise nearly half of all male babies who came into contact with facilities providing such services within 60 days after birth. The target was set in 2014 in a pilot project in Migori, Homa Bay, Kisumu and Siaya counties. If successful, the exercise would have been rolled out countrywide.

    September 9, 2021
    The Star
  • One of the most important developments in HIV in the last decade is the discovery that taking a pill combining two antiretroviral medicines every day can prevent HIV infection. This pill is finally becoming widely available in South Africa’s public healthcare system, but uptake is still relatively low.

    September 9, 2021
    Spotlight
  • A global evidence review suggests digitally-supported HIV self-testing increases uptake, engages first-time and hard-to-reach testers, and successfully links people to HIV treatment.

    September 9, 2021
    General
    Avert
  • When the coronavirus pandemic hit in early 2020, the Global Fund to Fight AIDS, Tuberculosis and Malaria launched a funding mechanism to help protect the gains made in the fight against the three diseases. But the damage from the pandemic was still significant.

    September 9, 2021
    General
    Devex
  • Like all of 2021, the summer of 2016 was a tumultuous, anxiety-inducing time. There was a highly contentious election and, for the LGBTQ+ and Latinx communities, a searing tragedy with the Pulse massacre. Amid the stressors was a huge dose of positivity: the birth of a movement called U=U, or undetectable equals untransmittable.

    September 8, 2021
    HIV Plus Mag
  • Men over the age of 35 in South Africa are not taking up COVID-19 vaccines at the same rate as women. Only about 40 percent of those who had been vaccinated by 13 August were men, according to a health department report.

    September 8, 2021
    General
    Bhekisisa
  • The COVID-19 pandemic has severely set back the fight against other global scourges like HIV, tuberculosis and malaria, according to a sobering new report released on Tuesday. Before the pandemic, the world had been making strides against these illnesses. Overall, deaths from those diseases have dropped by about half since 2004. “The advent of a fourth pandemic, in COVID, puts these hard-fought gains in great jeopardy,” said Mitchell Warren, executive director of AVAC....

    September 7, 2021
    General
    New York Times
  • An analysis of HIV pre-exposure prophylaxis among adults in an integrated health care system found high rates of initiation but gaps in the continuum of care that disproportionately affected vulnerable populations, including minorities and people with substance use disorders.

    September 7, 2021
    Contagion Live
  • On Aug. 12, three members and one former member of the Black AIDS Institute’s (BAI) board of directors sent out a public letter accusing the six remaining board members of jeopardizing the survival of the organization. The three who were still on the board followed up with an email to the HIV/AIDS advocacy community Aug. 19 announcing their resignation and alleging that the remaining board members had created a toxic work environment, “illegally” voted to remove them, and terminated the employment of the organization’s now-former president and CEO, Raniyah Copeland, MPH.

    September 3, 2021
    General
    The Body
  • Transgender people faced a much higher mortality rate than cisgender peers, according to a new Dutch study. Some of the largest drivers of this unexpectedly high death rate were cardiovascular disease, lung cancer, HIV-related disease, and suicide. More specifically, transgender women had a 47.6-fold and 14.7-fold higher mortality rate due to HIV than general population women and men, respectively — the highest driver of deaths in this population.

    September 2, 2021
    General
    MedPage Today

Published Research

Announcements